Immunization and vaccines related implementation research advisory committee (IVIR-AC) - September 2022

12 – 16 September 2022

 

  • Session 1: COVID 19 vaccine impact modelling
  • Session 2: Full Value of improved Influenza Vaccine Assessment
  • Session 3: Influenza Vaccine Global Demand Forecasting tool
  • Session 4: Pneumococcal Conjugate Vaccine use in humanitarian crises
  • Session 5: Measles Case Fatality Ratio estimation
  • Session 6: TB Full Value of Vaccine Assessment (FVVA)
  • Session 7: MR-MAP initial Full Value of Vaccine Assessment (MR-MAP iFVVA)
  • Session 8: IA2030 vaccine impact estimates
  • Session 9: VIMC 

Meeting materials

Meeting report

 

Related

Background materials

IVIR-AC Pink Book September 2022
(download file and open in PDF viewer for access to full content)